Problem statement: Answer the multiple-choice question.
Question: Which compound exhibits a -1.161% human ether-à-go-go related gene (hERG) inhibition at a concentration of 10uM?
Constraint: You must select none, one or more options from a, b, c, d, or e without using any other words.
Options:
a: Cc1ccc(CN2CCN(Cc3c[nH]c4ccccc34)CC2CCO)o1
b: CCCNC(=O)c1onc(CSc2ccc(Cl)cc2)c1C(=O)NCCC(C)C
c: COc1ccc(CCNC(=O)CSc2n[nH]c(C)c2[N+](=O)[O-])cc1OC
d: CCc1ccc(/C([O-])=C(/C(=S)NCCN2CCOCC2)[n+]2ccccc2)cc1
e: N#CCCN/N=C(/Cc1nc2ccccc2[nH]1)c1ccc(Cl)cc1
Answer: b. CCCNC(=O)c1onc(CSc2ccc(Cl)cc2)c1C(=O)NCCC(C)C
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCCNC(=O)c1onc(CSc2ccc(Cl)cc2)c1C(=O)NCCC(C)C
CCCNC(=O)c1onc(CSc2ccc(Cl)cc2)c1C(=O)NCCC(C)C
3-[(4-chlorophenyl)sulfanylmethyl]-4-N-(3-methylbutyl)-5-N-propyl-1,2-oxazole-4,5-dicarboxamide